A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers and artificial intelligence, to transform ...
Researchers have found that patients with interstitial lung disease (ILD) are at greatly heightened risk of developing all ...
TipRanks on MSN
AbbVie’s Promising Phase 1 Study on ABBV-CLS-579: A Potential Game-Changer in Cancer Treatment
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently completed a Phase 1 clinical study titled ‘A Phase 1, ...
Chemotherapy plus anti-PD-1 or anti-PD-L1 in advanced PD-L1–negative squamous cell lung carcinoma: A systematic review and meta-analysis. First-line camrelizumab plus chemotherapy in patients with ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ -- USA News Group News Commentary – The FDA's accelerated approval of two oncology treatments in August 2025[1] ...
Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC-Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa These findings ...
Individuals with interstitial lung disease (ILD) had more than a 13-fold higher incidence rate of lung cancer than those without ILD. The association persisted after adjustment for confounders, was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback